Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898882 · ClinicalTrials.gov registry record
Pharmacokinetics of Oxytocin at Cesarean Delivery
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 30
- Enrollment target
NCT03898882 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants.
The verdict
NCT03898882 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The primary objective is to obtain data to inform the design of a population pharmacokinetic study of oxytocin after administration at CD as per standard institutional practice.
Interventions
- DEVICE Shore durometer
- DRUG oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-05-24 |
| Est. Completion | 2020-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03898882
The ClinicalTrials.gov registry entry for NCT03898882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Shore durometer is the first listed.
NCT03898882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03898882 about?
NCT03898882 is a clinical study titled "Pharmacokinetics of Oxytocin at Cesarean Delivery". The primary objective is to obtain data to inform the design of a population pharmacokinetic study of oxytocin after administration at CD as per standard institutional practice.
What is the current status of trial NCT03898882?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-05-24. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03898882?
The interventions under investigation include: Shore durometer (DEVICE), oxytocin (DRUG).
Who is sponsoring clinical trial NCT03898882?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.